TRANSGLYCIT Trademark
Serial Number: 79328793 • Registration: 6982533
TRANSGLYCIT is a trademark filed by
Genovis AB
on November 10, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Charles P. Guarino Moser Taboada
1040 Broad Street - Suite 103
Shrewsbury
NJ 07702
United States
Trademark Details
Filing Date
November 10, 2021
Registration Date
February 21, 2023
Published for Opposition
December 6, 2022
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 13, 2023 FINV
FINAL DISPOSITION NOTICE SENT TO IB
May 23, 2023 FICS
FINAL DISPOSITION PROCESSED
May 23, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 21, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 21, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 21, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Dec 12, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 6, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 6, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 23, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 23, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 16, 2022 NONP
REFUSAL PROCESSED BY IB
Nov 14, 2022 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 2, 2022 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 21, 2022 RFCS
REFUSAL PROCESSED BY MPU
Oct 21, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 30, 2022 RFCR
NON-FINAL ACTION WRITTEN
Aug 29, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 22, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 22, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 16, 2021 REPR
